Largest disclosed lower bound
Virginia Foxx · $15.0K–$50.0K
Sale · traded 2023-08-29 → filed 2023-09-05. Ranked over every TAK row by the provable lower bound, never a point estimate.
Public record / Tickers / TAK
TAK — TAKEDA PHARMACEUTICAL CO LTD†
Both disclosure regimes on one name: who in Congress filed about TAK, which institutions reported holding it. Each section keeps its own clock — congressional trades on the 45-day PTR clock, 13F holdings as quarter-end snapshots.
- Congress txns
- 8 all PTR rows naming TAK
- Members · 12m
- 0 0 buys · 0 sells · by trade date
- Latest PTR
- 09-05 filed 2023-09-05
- 13F holders
- — ticker not resolved to an issuer
Congress = transactions in statutory ranges, 45-day lag · Institutions = quarter-end positions, 45-day lagas of 2026-09-14 13:21 UTCno price data — a disclosure record, not a chart
Congress · trailing 12 months
No member disclosed TAK in the trailing 12 months
Counts of disclosures by trade date, not dollars — ranges cannot be netted across members. Flow ranges per member are in the table below.
Timeliness
Every row filed inside the 45-day window
Late disclosure is stated on the row, never editorialised. Both dates and the receipt stay on every row.
Congress · disclosure timeline
TRADE DATES · 24M · ▲ BUY ▼ SELL · HEIGHT = LOG LOWER BOUNDNo dated TAK rows fall inside the trailing 24 months by trade date.
Trade date, not filing date — the lag lives in the table below. 0 rows placed.
PLANNED institutional holder flow by quarter
Congressional disclosures
ALL PTR ROWS NAMING TAK · SORTED FILED ↓ · STATUTORY RANGES · FILED ≤45D LATEfull congressional view ↗| Filed ▾ | Member | Side · Owner | Traded · Lag | Amount | Range · Flags | Src |
|---|---|---|---|---|---|---|
| 2023-09-05 | Virginia Foxx R–NC-5 | Sale · JT (jointly owned) | Traded 08-29 +7d | $15K–$50K | ||
| 2023-08-13 | Daniel S. Goldman D–NY-10 | Sale | Traded 07-10 +34d | $15K–$50K | ||
| 2023-03-20 | Daniel S. Goldman D–NY-10 | Purchase | Traded 02-27 +21d | $1K–$15K | ||
| 2023-03-03 | Virginia Foxx R–NC-5 | Purchase · JT (jointly owned) | Traded 02-16 +15d | $1K–$15K | ||
| 2022-12-06 | Virginia Foxx R–NC-5 | Purchase · JT (jointly owned) | Traded 11-01 +35d | $1K–$15K |
Traded → filed dates on every rowEach row shows the trade date and the filing date; the gap between them is the disclosure lag.all 8 ↗
Members active in TAK
12M · NET LOWER BOUND · COMMITTEES AS OF TRADE DATE · SNAPSHOT 2026-09-14No member disclosed TAK in the trailing 12 months.
Congress ↔ notable managers · TAK
who in Congress disclosed purchases or sales beside which notable managers added or trimmedCongress · last 90 days
- Buyers
- 0 — —
- Sellers
- 0 — —
filed 2026-06-16 → 2026-09-14 · totals are statutory ranges
Notable managers PLANNED
Ticker not yet mapped — the 13F side needs a reviewed name-and-class mapping row for TAK. how tickers are mapped ↗
No moves on either side in the window.
Institutional holders · 13F
Mapped, but not in the published aggregate.
TAK resolves to TAKEDA PHARMACEUTICAL CO LTD (CIK 0001395064), but this build's aggregate holds no entity-keyed top-holder rows for it. TAK on SEC EDGAR ↗
Crowding — not available in this build. The ticker resolves to TAKEDA PHARMACEUTICAL CO LTD (CIK 0001395064), but this build's aggregate holds no entity-keyed holder rows for it — its 13F securities are provisional identities without a CUSIP→issuer bridge — so it cannot be ranked among tracked names.
Do the two regimes agree?
TRAILING 12M · CONGRESS vs FILERS NETCongress net (rows)no rows
Congress net ($ bound)$0
Filers net (actions)not in build
Filers net ($ Q/Q)not in build
The ticker resolves to TAKEDA PHARMACEUTICAL CO LTD (CIK 0001395064), but this build's aggregate holds no entity-keyed holder rows for it — its 13F securities are provisional identities without a CUSIP→issuer bridge — so the filer side cannot be computed. Convergence and divergence are stated only when both sides are computed.
Signals on TAK
RETAINED WINDOW · ACTIVE HITSZero hits on TAK in the retained window — a computed answer over every rule, not missing coverage.
Planned modules for TAK · financials and macro
Financials — as filed PLANNED
TAK's as-reported XBRL fundamentals will appear here when the financials module passes its gates. Until then: TAK on EDGAR ↗
Macro context PLANNED
Rates, inflation, and positioning series land here with the macro module — vintage-aware, never nowcast.
† issuer name from the SEC's present-day ticker file (company_tickers.json) — a present-day mapping, not the name as of each filing